Skip to content

Avitene 1050040Recalls & reported problems

Davol Inc. · Avitene Ultrafoam, 8 cm x 12.5 cm (3-1/8" x 5"), 100 sq cm · Class 3 · Implant

All models of Avitene (8)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00801741010545), received between Sep 6, 2023 and Sep 6, 2023 — classified as 1 malfunction.

The most frequently reported specific device problem is “Device Contamination with Chemical or Other Material” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Device Contamination with Chemical or Other Material1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionSep 6, 2023Device Contamination with Chemical or Other Material; Device Contamination with Chemical or Other Material

    AS REPORTED, DURING A PROCEDURE, THE SURGICAL TECH ON THE STERILE FIELD CUT INTO THE AVITENE ULTRAFOAM AND A SHORT BLACK HAIR EMERGED FROM THE INSIDE OF THE FOAM. THERE WAS NO REPORTED PATIENT INJURY.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17690637 ↗

Other Agent, absorbable hemostatic, collagen based devices

All Agent, absorbable hemostatic, collagen based devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page